Advertisement

Prevalence of Clinical and Isolated Subclinical Cardiovascular Disease in Older Adults With Glucose Disorders

The Cardiovascular Health Study

  1. Joshua I. Barzilay, MD1,
  2. Charles F. Spiekerman, PHD2,
  3. Lewis H. Kuller, MD3,
  4. Gregory L. Burke, MD4,
  5. Vera Bittner, MD5,
  6. John S. Gottdiener, MD6,
  7. Fred L. Brancati, MD7,
  8. Trevor J. Orchard, MD3,
  9. Daniel H. O’Leary, MD8 and
  10. Peter J. Savage, MD9
  1. 1Division of Endocrinology, Kaiser Permanente of Georgia, and Division of Endocrinology, Emory University School of Medicine, Atlanta, Georgia
  2. 2Department of Biostatistics, University of Washington, Seattle, Washington
  3. 3Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania
  4. 4Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina
  5. 5Department of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama
  6. 6Department of Cardiology, St. Francis Hospital, Roslyn, New York
  7. 7Department of Epidemiology, Johns Hopkins School of Hygiene and Public Health, Baltimore, Maryland
  8. 8Department of Radiology, Tufts–New England Medical Center, Boston, Massachusetts
  9. 9Division of Epidemiology and Clinical Applications, National Heart, Lung, Blood Institute, National Institutes of Health, Bethesda, Maryland

    Abstract

    OBJECTIVE—Clinical cardiovascular disease (CVD) is highly prevalent among people with diabetes. However, there is little information regarding the prevalence of subclinical CVD and its relation to clinical CVD in diabetes and in the glucose disorders that precede diabetes.

    RESEARCH DESIGN AND METHODS—Participants in the Cardiovascular Health Study, aged ≥65 years (n = 5,888), underwent vascular and metabolic testing. Individuals with known disease in the coronary, cerebral, or peripheral circulations were considered to have clinical disease. Those without any clinical disease in whom CVD was detected by ultrasonography, electrocardiography, or ankle arm index in any of the three vascular beds were considered to have isolated subclinical disease.

    RESULTS—Approximately 30% of the cohort had clinical disease, and ∼60% of the remainder had isolated subclinical disease. In those with normal glucose status, isolated subclinical disease made up most of the total CVD. With increasing glucose severity, the proportion of total CVD that was clinical disease increased; 75% of men and 66% of women with normal fasting glucose status had either clinical or subclinical CVD. Among those with known diabetes, the prevalence was ∼88% (odds ratio [OR] 2.46 for men and 4.22 for women, P < 0.0001). There were intermediate prevalences and ORs for those with impaired fasting glucose status and newly diagnosed diabetes.

    CONCLUSIONS—Isolated subclinical CVD is common among older adults. Glucose disorders are associated with an increased prevalence of total CVD and an increased proportion of clinical disease relative to subclinical disease.

    Footnotes

    • Address correspondence and reprint requests to Joshua Barzilay, MD, Kaiser Permanente of Georgia, 200 Crescent Center Parkway, Tucker, GA 30084. E-mail: joshua.barzilay{at}kp.org.

      Received for publication 19 December 2000 and accepted in revised form 26 March 2001.

      A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

    | Table of Contents
    Advertisement